BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -39.60M | -46.85M | -60.84M | -46.66M | |
| Depreciation & Amort | -- | 942.00K | 957.00K | 1.09M | 1.25M | |
| Capital Expenditure | -- | -1.07M | -633.00K | -2.54M | -546.00K | |
| Free Cash Flow | -- | -40.66M | -47.49M | -63.38M | -47.21M | |
| Investing Cash Flow | -- | 16.13M | -38.26M | -26.10M | 37.80M | |
| Financing Cash Flow | -- | 126.00K | 97.90M | 89.82M | 141.00K |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--